Aug 19, 2025 • Zacks Commentary
BULLISH
Pediatrix Medical Refills Its Buyback Prescription With $250M Dose
MD launches a $250M buyback, fueled by stronger cash flow, leaner operations and robust 2025 profit outlook.
Aug 18, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pediatrix Medical Group ( MD ) Is Up 11.93% in One Week: What You Should Know
Does Pediatrix Medical Group (MD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aug 14, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pediatrix Medical Group ( MD ) Is Attractively Priced Despite Fast-paced Momentum
Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Aug 12, 2025 • Zacks Commentary
BULLISH
Here's Why Pediatrix Medical Group ( MD ) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Aug 08, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.
Aug 05, 2025 • Motley Fool
SOMEWHAT-BULLISH
Pediatrix ( MD ) Q2 EPS Jumps 56%
Pediatrix Medical Group ( NYSE:MD ) , a leader in neonatal and maternal-fetal healthcare services, reported its second-quarter 2025 earnings on August 5, 2025. The company delivered a standout quarter, with non-GAAP earnings per share ( EPS ) of $0.53, beating analyst expectations of $0.42 by ...